Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers

Leendert H. Zaaijer, Helena C. van Doorn, Marian J. E. Mourits, Marc van Beurden, Joanne A. de Hullu, Muriel A. Adank, Luc R. C. W. van Lonkhuijzen, Hans F. A. Vasen, Brigitte F. M. Slangen, Katja N. Gaarenstroom, Ronald P. Zweemer, Peggy M. L. H. Vencken, Caroline Seynaeve, Mieke Kriege*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1174-1178
JournalBritish Journal of Cancer
Issue number10
Publication statusPublished - 8 Nov 2016


  • BRCA mutation
  • breast cancer
  • ovarian cancer
  • survival
  • chemotherapy

Cite this